Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Clarient, Inc. (CLRT)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CLRT
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Are We Re-Running 1999?
Oct 23
•
The Pragmatic Capitalist
•
6 Comments
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline
Oct 14
•
Zacks.com
•
Comment!
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
Jul 1
•
M. E. Garza
•
Comment!
Clarient: New Breast-Cancer Test
May 5
•
Douglas Cress
•
1 Comment
Notes on CDS Market, De-Risking and Re-Risking
Apr 22
•
Tyler Durden
•
5 Comments
Clarient: A Fresh Start After Relief from Bad Debt
Apr 15
•
The Inflection Point
•
Comment!
Tracking Cancer Diagnostic and Therapeutic Stocks
Apr 13
•
Mike Havrilla
•
6 Comments
Winning Stocks in the Age of Personalized Medicine
Mar 4
•
John Putnam
•
Comment!
Create Your Own Diagnostics ETF
Jan 21
•
Mike Havrilla
•
3 Comments
20 Emerging Healthcare Stocks to Watch in '09
Jan 11
•
Mike Havrilla
•
4 Comments
New Emerging Diagnostics Index
Dec 26, 2008
•
Mike Havrilla
•
2 Comments
Today's Market Moving Stories: Election Day
Nov 4, 2008
•
The Mole
•
Comment!
Clarient: With Quarterly Revenues Up 59%, Take a Look
Nov 2, 2008
•
Douglas Cress
•
Comment!
Clarient Adds New Tool to Screen Biomarkers
Sep 30, 2008
•
Douglas Cress
•
Comment!
Clarient: Clearly a Winner
Aug 11, 2008
•
Douglas Cress
•
Comment!
Interview with Jim Datin, Executive VP & Managing Director of Safeguard Scientifics
May 13, 2008
•
Douglas Cress
•
Comment!
Interview with Ron Andrews, President & CEO of Clarient
Mar 17, 2008
•
Douglas Cress
•
Comment!
CombiMatrix and Clarient Partner to Market a More Sophisticated Cancer Test
Feb 5, 2008
•
Douglas Cress
•
Comment!
Clarient, Inc.: Clarifying the Complexities of Cancer
Dec 30, 2007
•
Mike Havrilla
•
2 Comments
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
7 Comments
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
3 Comments
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
3 Comments